Abstract-Arterial aging may link cardiovascular risk to white coat hypertension (WCH). The aims of the present study were to investigate the role of arterial aging in the white coat effect, defined as the difference between office and 24-hour ambulatory systolic blood pressures, and to compare WCH with prehypertension (PH) with respect to target organ damage and long-term cardiovascular mortality. A total of 1257 never-been-treated volunteer subjects from a community-based survey were studied. WCH and PH were defined by office and 24-hour ambulatory blood pressures. Left ventricular mass index, carotid intima-media thickness, estimated glomerular filtration rate, carotid-femoral pulse wave velocity, carotid augmentation index, amplitude of the reflection pressure wave, and 15-year cardiovascular mortality were determined. Subjects with WCH were significantly older and had greater body mass index, blood pressure values, intima-media thickness, carotid-femoral pulse wave velocity, augmentation index, amplitude of the backward pressure wave, and a lower estimated glomerular filtration rate than PH. Amplitude of the backward pressure wave was the most important independent correlate of the white coat effect in multivariate analysis (model r 2 =0.451; partial r 2 /model r 2 =90.5%). WCH had significantly greater cardiovascular mortality than PH (hazard ratio, 2.94; 95% confidence interval, 1.09-7.91), after accounting for age, sex, body mass index, smoking, fasting plasma glucose, and total cholesterol/high-density lipoprotein-cholesterol ratio. Further adjustment of the model for amplitude of the backward pressure wave eliminated the statistical significance of the WCH effect. In conclusion, the white coat effect is mainly caused by arterial aging. WCH carries higher risk for cardiovascular mortality than PH, probably via enhanced wave reflections that accompany arterial 
H ypertension is the most important cardiovascular disease (CVD) risk factor and its control remains unsuccessful in almost all countries of the world. 1 Early detection of subjects with high risk for sustained hypertension (SH) may facilitate the implementation of a high-risk strategy for the prevention of CVD. 2 On the basis of office blood pressure measurements, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) has introduced a category, prehypertension (PH), for those with blood pressures ranging from 120 to 139 mm Hg systolic and 80 to 89 mm Hg diastolic. 3 PH is considered as an early sign of developing SH and has been correlated with a >2-fold increase in the risk of developing CVD compared with blood pressure levels <120/80 mm Hg. [3] [4] [5] [6] However, discrepancies between office and out-of-office blood pressure measurements have been recognized by home or ambulatory blood pressure monitoring (ABPM) and new blood pressure categories, such as masked hypertension and white coat hypertension (WCH), are identified from the out-of-office blood pressure measurements. 7 Masked hypertension, characterized by a normal office blood pressure but high out-of-office blood pressure, is an adverse condition that should be treated as SH. 8, 9 In contrast, WCH, defined by a high office blood pressure but normal out-of-office blood pressure, 7 is generally recognized as a benign entity as compared with SH. 8, [10] [11] [12] [13] Current guidelines, therefore, emphasize the importance of identifying WCH to reduce the risk of inappropriate pharmacological treatment for hypertension in normotensive subjects. 3, 14 Several studies, however, have reported the association of WCH with target organ damage or dysfunction and have suggested that it may not be prognostically innocent. [15] [16] [17] [18] [19] [20] Arterial aging increases arterial stiffness and wave reflections and is the major independent risk factor for the development of SH 21 and CVD. 22, 23 Because WCH becomes more common with increasing age, 14 arterial aging may play a role in the pathogenesis of WCH and its associated CVD risk. In this regard, WCH may also be justified as a form of prehypertension. We hypothesized that WCH is more important and useful than PH in identifying subjects with high risk of developing SH and CVD in an aging society. The purposes of the present study, therefore, were to investigate, in a community-based population, the relationships of arterial aging to the white coat effect, and PH and WCH to target organ indices and 15-year CVD mortality.
Methods

Study Cohort
In 1992 to 1993, 2230 Chinese residents in Pu-Li town and Kinmen county, Taiwan, were invited to participate in a comprehensive cardiovascular survey, including medical history and physical examination, arterial tonometry and ultrasonography, echocardiography, 24-hour ABPM, and biochemical examinations in the fasting state. 24 Among 2039 participants with ABPM, a total of 1257 never-beentreated subjects (47% women, aged 53±13 years) were included in the present study cohort (Figure 1 ). All participants gave informed consent, and the study was approved by the institutional review board at the Johns Hopkins University.
Office Blood Pressure Measurements
After >5 minutes of full rest, 2 to 3 measurements of brachial systolic (SBP) and diastolic (DBP) blood pressures separated by >5 minutes were taken from the right arm in the seated position with a mercury sphygmomanometer and a standard-sized cuff (13×50 cm) by 1 of 4 experienced cardiologists who had been informed of the standard procedures. Pulse pressure was the difference between SBP and DBP. Averaged blood pressure values were used for all statistical analysis. 25, 26 
Ambulatory Blood Pressure Monitoring
Average 24-hour, daytime, and nighttime SBP (SBP-24h, SBP-D, and SBP-N, respectively) and DBP (DBP-24h, DBP-D, and DBP-N, respectively), and heart rate (HR-24h, HR-D, and HR-N, respectively) were derived from the oscillometric monitors (Model 90207, SpaceLabs Inc, Redmond, WA). SBP variability (SBPV; SBPV-24h, SBPV-D, SBPV-N, respectively) and heart rate variability (HRV; HRV-24h, HRV-D, HRV-N, respectively) were the SDs of SBP-24h, SBP-D, SBP-N, HR-24h, HR-D, and HR-N, respectively.
Well-trained staffs set up the ABPM devices 1 day before the office visit on weekday mornings. Participants were instructed to maintain their daily activities. Automated blood pressure measurements were taken at 20-and 60-minute intervals during the daytime (0700-2200 hours) and nighttime (2200-0700 hours), respectively. 24, 27 Blood pressure readings were not edited manually.
24,27
Arterial Stiffness and Wave Reflections
Carotid-femoral pulse wave velocity (PWV) was calculated from the surface distance and the foot-to-foot pulse transit time between the right common carotid and right femoral arteries, using a tape measure and ECG-gated Doppler flow velocity signals (Parks model 802, Parks Medical Electronics, Inc). 25 The magnitude of the wave reflections was estimated by calculating augmentation index (AIx) and amplitude of the backward pressure wave (Pb) from a calibrated ensemble averaged carotid artery pressure waveform registered with a tonometer (model SPC-350, Millar Instruments, Inc). 25 The inflection point on the carotid pressure waveform for the calculation of AIx was identified using the zero-crossing timings of the fourth derivative of the pressure wave. 25 The carotid pressure waveform was separated into its forward and reflected components using the triangulation method 28 according to the following equations:
where Pm(t) is the carotid pressure wave, F(t) the approximated triangular-shaped flow wave, Zc the characteristic impedance, Pf(t) the decomposed forward pressure component, and Pb(t) is the decomposed backward pressure component.
25
Variables of Target Organ Indices
All echocardiographic examinations were performed by the same sonographer on a Hewlett-Packard SONOS 500 U (Hewlett-Packard, Andover, MA) incorporated with a 2.5-MHz transthoracic probe and a 7-MHz vascular probe. 29 Images during sinus rhythm were measured for ≥3 cardiac cycles, and all measurements were averaged for data analysis. Left ventricular mass was calculated from 2-dimensionalguided M-mode echocardiography and indexed to body surface area (left ventricular mass index [LVMI] ). Intima-media thickness (IMT) of the posterior wall of the right common carotid artery was measured at end-diastole. Estimated glomerular filtration rate (eGFR) was calculated with previously published formula for Chinese.
26
Classification
Participants were classified into 4 groups on the basis of office blood pressure and daytime ABPM levels: (1) normotension (NT; n=250; 19.9%), office blood pressure <120/80 mm Hg and daytime ABPM blood pressure <135/85 mm Hg; (2) PH (n=318; 25.3%), office blood pressure ≥120/80 and <140/90 mm Hg, and daytime ABPM blood pressure <135/85 mm Hg; (3) WCH (n=153; 12.2%), office blood pressure ≥140/90 mm Hg and daytime ABPM blood pressure <135/85 mm Hg; and (4) SH (n=536; 42.6%), daytime ABPM blood pressure ≥135/85 mm Hg. 3 White coat effect was defined as the difference between office SBP and ABPM SBP-24h.
Follow-Up
Mortality statistics for the 1257 participants were obtained by linking our database with the National Death Registry. The National Death Registry database registers valid information on the basis of the certified death certificates coded according to the International Classification of Disease, Ninth Revision (ICD-9). The ICD-9 codes for cardiovascular death were 390 to 459. Subjects not appearing on the National Death Registry on December 31, 2007 were considered as survivors. 25 
Statistical Analysis
Characteristics of subjects are presented as mean±SD or number (%). The 4 groups were compared via a 1-way ANOVA and post hoc 
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Bonferroni test for continuous variables. Categorical variables were compared with χ 2 test. Because of significant age differences among the groups, the estimated marginal mean values were used for adjusting LVMI, IMT, eGFR, PWV, AIx, and Pb for age. Determinants of the white coat effect were examined by simple correlation and stepwise multiple linear regression analysis. The incidence of total and CVD mortality was calculated by dividing the number of total or CVD deaths at the end of follow-up by the total number of personyears of follow-up. CVD survival curves among groups were estimated using Kaplan-Meier product-limit method and compared a logrank test with pairwise comparisons. A Cox proportional hazards model was used to estimate the relative risks of all-cause and CVD mortality between groups, adjusting for conventional risk factors. Effects of arterial stiffness and wave reflections on the relative risks Table 1 presents the characteristics at the baseline survey. PH was 3 years older than NT, SH was 4 years older than PH, and WCH was 3 years older than SH. SH had more men than NT. Body mass index significantly increased in the order of NT, PH, WCH, and SH. WCH and SH had significantly higher total cholesterol/high-density lipoprotein-cholesterol and fasting plasma glucose levels than NT or PH. PH had significantly higher total cholesterol/high-density lipoprotein-cholesterol than NT. All office and ambulatory blood pressure values (SBP, DBP, and pulse pressure) and SBPV increased significantly in the order of NT, PH, WCH, and SH, except that brachial pulse pressure did not significantly differ between WCH and SH ( Table 1 ). The office heart rate was significantly higher in PH and SH than in NT, whereas HR-24h and HR-N were only significantly higher in SH than the other 3 groups. In contrast, HR-D in WCH was significantly lower than that in PH and SH. According to JNC-7, 73.2% of WCH fell into stage 1 hypertension and 53.9% of SH had stage 2 hypertension.
Results
Baseline Characteristics
WCH and SH, respectively, had 47.1% and 17.5% isolated systolic hypertension (SBP≥140 mm Hg and DBP<90 mm Hg). Among the 4 groups, WCH had the highest white coat effect, followed by SH, PH, and NT.
Target Organ Indices Among Groups
Compared with NT, PH had significantly higher PWV and Pb, but similar LVMI, IMT, eGFR, and AIx (Table 1) . Compared with PH, WCH had significantly higher IMT, PWV, AIx, and Pb, but similar LVMI and eGFR. Compared with WCH, SH had significantly higher LVMI but similar IMT, eGFR, PWV, AIx, and Pb. After adjustment for age, WCH still had significantly higher IMT, PWV, AIx, and Pb than PH (Figure 2 ).
Determinants of White Coat Effect
The white coat effect was significantly positively correlated with age ( Figure 3A) , body mass index, total cholesterol/ high-density lipoprotein-cholesterol, fasting plasma glucose, SBPV-24h, SBPV-D, SBPV-N, LVMI, IMT, PWV, AIx, and Pb ( Figure 3B ), and was significantly negatively correlated with male sex, eGFR, HR-24h, HR-D, HR-N, HRV-24h, HRV-D, and HRV-N ( Table 2) . HR-D, SBPV-D, and HRV-24h best correlated with the white coat effect among the variables of heart rate, SBPV, and HRV, respectively. By stepwise multiple linear regression analysis, Pb, LVMI, SBPV-D, fasting plasma glucose levels, male sex, HRV-24h, age, and PWV were significantly independently associated with the white coat effect in descending order of importance ( Table 2 ). Pb alone explained 90.5% (partial r 2 /model r 2 ) of the total explainable variance of the white coat effect.
Mortality Among the 4 Blood Pressure Categories
During a median follow-up period of 15 years (17 128 personyears), 272 subjects died and 73 with a CVD cause (26.8%). The incidence of all-cause and CVD mortality was 9.7 and 0.6 in NT, 11.0 and 1.4 in PH, 24.6 and 6.5 in WCH, and 19.5 and 7.2 per 1000 person-years in SH. Table 3 displays hazard ratios (HR) and 95% confidence intervals for all-cause mortality by blood pressure categories. With NT as the reference (HR=1), PH had a crude HR similar to NT, whereas WCH and SH had significantly higher HRs (model 1). However, the higher HRs in WCH and SH became statistically insignificant after adjustment for age, sex, body mass index, smoking, fasting plasma glucose, and total cholesterol/high-density lipoprotein-cholesterol ratio (model 2). However, with PH as the reference (HR=1) and after adjustment for age, sex, body mass index, smoking, fasting plasma glucose, and total cholesterol/high-density lipoprotein-cholesterol ratio (model 3), WCH had a nonsignificantly higher HR and SH had a significantly higher HR than PH. Table 4 displays HR and 95% confidence interval for CVD mortality by blood pressure categories. With NT as the reference (HR=1), PH, WCH, and SH all had a higher crude HR but only the latter 2 groups reached statistical significance (model 1). The higher HRs in WCH and SH remained statistically significant after adjustment for age, sex, body mass index, smoking, fasting plasma glucose, and total cholesterol/high-density lipoproteincholesterol ratio (model 2). Furthermore, with PH as the reference (HR=1) and after the same adjustment (model 3), both WCH and SH had a significantly higher HR than PH. WCH still had a significantly higher HR than PH with further adjustment for carotid-femoral PWV (model 4), but the significance disappeared when AIx (model 5) or Pb (model 6) was adjusted instead. Figure 4A shows the Kaplan-Meier CVD survival curves for the 4 blood pressure groups. NT and PH had near overlapping survival curves without significant difference (P=0.293). Both WCH and SH had significantly worse survival than PH (both P<0.001). When WCH was stratified by Pb (median of the WCH cohort, 17.7 mm Hg), WCH with high Pb but not with low Pb had significantly greater CVD mortality than PH ( Figure 4B ). In addition, the survival curve of WCH with high Pb overlapped with that of SH (P=0.938).
Discussion
Clinically, patients with PH defined by office blood pressure criteria are considered at increased risk for progression to SH. AIx indicates carotid augmentation index; HDL, high-density lipoprotein; HR-24h, average 24-hour heart rate; HR-D, average daytime heart rate; HR-N, average nighttime heart rate; HRV-24h, average 24-hour heart rate variability; HRV-D, average daytime heart rate variability; HRV-N, average nighttime heart rate variability; eGFR, estimated glomerular filtration rate; LVMI, left ventricular mass index; IMT, intima-media thickness; PWV, carotid-femoral pulse wave velocity; Pb, amplitude of the backward pressure; SBPV-24h, average 24-hour systolic blood pressure variability; SBPV-D, daytime systolic blood pressure variability; and SBPV-N, nighttime systolic blood pressure variability. *P<0.001 and †P<0.01. In contrast, the clinical relevance of WCH is mainly to avoid unnecessary pharmacological treatment. 3, 14 To our knowledge, the present study is the first report on the comparison of these 2 important blood pressure categories. In the present study, subjects with PH defined by both office and out-of-office blood pressure measurements had significantly lower blood pressure values (office and ABPM) than WCH, implying less adverse effects on target organs and future CVD risk. 30 Indeed, both functional and structural vascular changes were more evident in WCH than in PH. Subjects with WCH experienced more CVD mortality than PH. The white coat effect was mainly determined by arterial aging. In addition, WCH with high wave reflections presented with substantial target organ damages ( Figure S1 in the online-only Data Supplement) and carried risk of CVD mortality equivalent to that of SH. This may imply that pharmacological therapy may be indicated in patients with WCH and high wave reflections, as in patients with SH.
Compared with NT, PH has long been associated with increased CVD events both in women and men. 4, 31 However, conflicting results indeed existed, and few studies had excluded the potential confounders of masked hypertension and comorbidities. 32, 33 Masked hypertension can reliably be diagnosed by self-measured blood pressure or ABPM and should be treated as SH. 8, 9 In the present study, the finding of a low CVD mortality in subjects with PH but without masked hypertension may suggest the need to search for the latter in the clinical evaluation of the former detected by office blood pressure measurements alone. The absence of masked hypertension in subjects with PH is reassuring with respect to continuation of the nonpharmocological treatment for the prevention of SH.
WCH is a CVD risk factor when compared with normotensive controls 19, 20 but has a relatively benign outcome when compared with mild SH. 34 However, other studies have reported a cardiovascular risk in WCH that is not significantly different from that in NT. 8, 12, 35 Apparently, substantial prognostic heterogeneity exists in WCH. The present study indicates that WCH may also be a marker of early arterial aging. 36 Measures of arterial aging, the magnitude of wave reflections in particular, may be useful in identifying a high-risk subgroup in subjects with WCH who may benefit from the pharmacological treatment as in patients with SH.
Compared with measures of ABPM, the transient blood pressure rise during clinical visits has been referred as the white coat effect and has been attributed to the alerting reactions. [37] [38] [39] Determinants of the white coat effect have been identified, including age, sex, body mass index, smoking, office blood pressure, and SBPV-D. [37] [38] [39] The present study confirmed that advancing age, female sex, and increased body mass index and SBPV-D were positively associated with the white coat effect. Moreover, we demonstrated for the first time that arterial aging is the dominant determinant of the white coat effect. Although the white coat effect is triggered by a stress-related sympathetic activation, the blood pressure response, caused by the enhanced cardiac contraction and peripheral vasoconstriction, may be markedly magnified in the presence of arterial aging, manifested as increased arterial stiffness and wave reflections measured in the office setting. Because arterial aging is a recognized major CVD risk factor, our study further suggests that arterial aging is the major pathophysiology that links WCH to increased CVD risk.
Study Limitations
The present study has several limitations. First, the study was relatively small for the 4 blood pressure categories, and the reported CVD event rate was relatively low in this homogenous Chinese population. Therefore, we may not have had sufficient power to demonstrate a significantly higher HR than PH for all-cause mortality (Table 3 ; model 3) and CVD mortality (Table 4 ; models 5 and 6) in some of the multivariate Cox proportional hazards analyses. However, the overall results should be sufficient to demonstrate that WCH is more risky than PH. Second, the age difference between PH and WCH was large, and the aging effect may not be fully accounted for by age adjustment in statistical models. Third, the pulsatile indices (PWV, AIx, and Pb) had been taken during the office procedures and those values were probably not relevant to the daily lives of the individuals. Although home and ABPM blood pressures are superior to the office blood pressure in the association of target organ damages and future cardiovascular events, 7, 27 it remains to be established whether the clinical values of the out-of-office measures of the pulsatile indices are also superior to the office measures. However, the present study clearly demonstrated the clinical value of high office blood pressure in the presence of normal out-of-office blood pressure (ie, the identification of WCH category), and the add-on value of high office Pb in WCH ( Figure 4B ; Table S1 ). Fourth, Pb was possibly mathematically related to the white coat effect because the former was derived from a carotid pressure waveform calibrated to office mean blood pressure (=DBP+1/3 pulse pressure) and DBP, and the latter was calculated directly from office SBP. However, when Pb was replaced by AIx, a calibration-independent wave reflection index, AIx alone explained 55.9% of the total explainable variance of the white coat effect in the stepwise regression analysis (Table S2) . Therefore, the observed strong relationship between Pb and the white coat effect was most likely physiological. Furthermore, information regarding comorbidities and medical treatments during the follow-up period was not available. Therefore, our findings may not be generalizable to other populations with older PH, younger WCH, or those with comorbidities (ie, high cardiovascular risk cohort).
Perspectives
Effective hypertension control programs involve early detection of the high-risk subjects for SH or its related CVD events. To this end, JNC-7 designated a new blood pressure category of PH. Our results suggest that the clinical management of PH can be refined by the application of ABPM or home blood pressure monitoring because PH without masked hypertension may carry only minimal CVD risk. However, arterial aging may be responsible for the prevalent WCH and its associated CVD risk. Measurement of arterial aging in subjects with WCH may be relevant to the identification of a high-risk subgroup within WCH that may require pharmacological treatment. Future studies are required to demonstrate whether treatments targeted to arterial aging are effective in reducing the risks for the development of SH and CVD events in WCH with increased wave reflections. • White coat effect is mainly caused by arterial aging.
• White coat hypertension (WCH) is more risky than prehypertension, probably via enhanced wave reflections that accompany arterial aging.
What Is Relevant?
• WCH is more important than prehypertension in early detection of subjects with high risk for sustained hypertension and the related cardiovascular disease.
• WCH with enhanced wave reflections may carry a cardiovascular risk equivalent to that of sustained hypertension.
Summary
Arterial aging may link cardiovascular risk to WCH. WCH with evidence of arterial aging should be more aggressively managed. 
Novelty and Significance
